These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26559090)

  • 21. High Expression of Serum UCA1 may be a Potential Biomarker for Clinical Diagnosis of Gastric Cancer.
    Shan L; Liu C; Ma C
    Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Zhang Y; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
    Sun Z; Zhang N
    World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer].
    Ubukata H; Katano M; Motohashi G; Kasuga T; Takemura A; Tabuchi T; Tabuchi T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1821-4. PubMed ID: 14619529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer.
    Li Y; Yang Y; Lu M; Shen L
    Hepatogastroenterology; 2011; 58(112):2166-70. PubMed ID: 22024091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.
    Shimada H; Noie T; Ohashi M; Oba K; Takahashi Y
    Gastric Cancer; 2014 Jan; 17(1):26-33. PubMed ID: 23572188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
    Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
    Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
    BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer.
    Tian SB; Yu JC; Kang WM; Ma ZQ; Ye X; Cao ZJ; Yan C
    Asian Pac J Cancer Prev; 2014; 15(15):6295-300. PubMed ID: 25124614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.
    Oue N; Sentani K; Noguchi T; Ohara S; Sakamoto N; Hayashi T; Anami K; Motoshita J; Ito M; Tanaka S; Yoshida K; Yasui W
    Int J Cancer; 2009 Nov; 125(10):2383-92. PubMed ID: 19670418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
    Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
    JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
    Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
    Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control.
    Shang X; Song C; Du X; Shao H; Xu D; Wang X
    Saudi Med J; 2017 Feb; 38(2):204-208. PubMed ID: 28133696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection.
    Liu X; Qiu H; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z; Sun X
    Oncotarget; 2016 Jun; 7(23):35446-53. PubMed ID: 27147574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients.
    Li L; Yin X; Meng H; Hu J; Yu Z; Xu J
    Yonsei Med J; 2020 Jan; 61(1):15-19. PubMed ID: 31887795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
    Gaspar MJ; Arribas I; Coca MC; Díez-Alonso M
    Tumour Biol; 2001; 22(5):318-22. PubMed ID: 11553862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
    Pectasides D; Mylonakis A; Kostopoulou M; Papadopoulou M; Triantafillis D; Varthalitis J; Dimitriades M; Athanassiou A
    Am J Clin Oncol; 1997 Aug; 20(4):348-53. PubMed ID: 9256887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.